Similarly, with an integrative approach, Yuan et al. 20 identified signature genes, including the aryl hydrocarbon receptor, that are involved in phospholipid and choline metabolism in hepatic steatosis and thus suggested new therapeutic strategies for fatty liver disease. The gene discussed is AHR; the disease is fatty liver disease.